Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of safety, tolerability and preliminary pharmacokinetics of GET 73 in healthy volunteers

Trial Profile

Study of safety, tolerability and preliminary pharmacokinetics of GET 73 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Aug 2018

At a glance

  • Drugs GET 73 (Primary)
  • Indications Alcoholism
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 10 Aug 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top